Clinical Trial Update: Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating radiofrequency ablation or photodynamic therapy for non-resectable hilar cholangiocarcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: University of Leipzig | Conditions: Hilar Cholangiocarcinoma | Phase 4 | Status: RECRUITING